Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.
Researchers race to put hydroxychloroquine to the test in a large study.
Researchers around the world are collaborating to provide solutions to immediate and future challenges.
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Molecular glues are a new type of medicine inspired by nature’s matchmakers.
Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.
Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
This site is intended for a global audience.